A Phase I trial of WT1-TCR cell therapy

Trial Profile

A Phase I trial of WT1-TCR cell therapy

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Jul 2017

At a glance

  • Drugs WT1 TCR-transduced T cells (Primary)
  • Indications Acute myeloid leukaemia; Myelodysplastic syndromes
  • Focus Adverse reactions
  • Most Recent Events

    • 11 Jul 2017 New trial record
    • 20 Jun 2017 According to a Cell Medica media release, this trial was conducted at at UCL and Imperial College London with funding from the UK charity Bloodwise.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top